Brazil's Vice President Geraldo Alckmin stayed at home Monday after being diagnosed with Covid-19, Agencia Brasil reported. Alckin is also Minister of Development, Industry, Trade, and Services.
Argentine health authorities Thursday announced that the Japanese-developed TAK-003 vaccine against dengue was already available in the South American country at a cost of AR$ 37,500 (around US$ 38, at the unofficial “blue” rate).
PD-1 inhibitor tislelizumab under review by Brazil’s National Health Surveillance Agency to treat non-small cell lung cancer and esophageal cancer
Future regional expansion planned in... | April 13, 2023
Health authorities in Brazil are investigating two mysterious deaths aboard the bulker Caravos Harmony, which arrived at the Amazon River port of Maca...
Brazil's National Health Surveillance Agency (Anvisa) Wednesday approved the return effective Nov. 25 of the mandatory use of face masks in airplanes and airports in a move to reduce the risk of COVID-19 contagion after a significant increase in the number of cases in recent weeks.
State Health authorities in Rio de Janeiro Monday confirmed the second local death of a monkeypox patient. It was a 31-year-old man who had been hospitalized for over a month.
A drug against Covid-19 developed at the Federal University of Minas Gerais (UFMG) and the Oswaldo Cruz Foundation (Fiocruz) will begin testing with a group of 432 volunteers, it was announced Monday.
Brazil's National Health Surveillance Agency (Anvisa) Thursday cleared the Health Ministry in separate but unanimous decisions to import and use the Jynneos / Imvanex vaccine and the drug Tecovirimat, both against monkeypox.
Brazil's National Health Surveillance Agency (Anvisa) has received a request for the emergency use of Pfizer's newest vaccine against COVID-19 which would be active against both the original and the Ômicron strain, subvariant BA.1.